VIRICA Trademark

Trademark Overview

On Friday, March 1, 2024, a trademark application was filed for VIRICA with the United States Patent and Trademark Office. The USPTO has given the VIRICA trademark a serial number of 98429871. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, September 18, 2024. This trademark is owned by Virica Biotech Inc.. The VIRICA trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:

Cell culture reagents for laboratory use; cell culture reagents for scientific and research purposes; antibody reagents for scientific purposes; diagnostic reagents for medical-scientific research use; chemical preparations for the use in the production of medicines; chemical preparations for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; biochemical preparations for scientific purposes; small molecules for use in increasing viral yield in vaccines and viral medicines; chemical and biochemical products for scientific use and for research, namely, chemical preparations for scientific purposes, laboratory and research use; chemical and biochemical products for scientific use and for research, namely, chemical preparations for scientific purposes, reagents for scientific and research use, in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and p...

Biological production in the field of gene therapy and cell therapies; scientific research and analysis in the field of gene and cell therapies; biological production in the field of vaccines; scientific research and analysis in the field of vaccines, process development and evaluation; research and development in the field of vaccines; testing services in the field of vaccines; laboratory research in the field of gene expression; research in the field of gene therapy; research and development in the medical biotechnology field; development of biotechnology; research and development in the pharmaceutical and biotechnology fields
virica

General Information

Serial Number98429871
Word MarkVIRICA
Filing DateFriday, March 1, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, September 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesCell culture reagents for laboratory use; cell culture reagents for scientific and research purposes; antibody reagents for scientific purposes; diagnostic reagents for medical-scientific research use; chemical preparations for the use in the production of medicines; chemical preparations for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; biochemical preparations for scientific purposes; small molecules for use in increasing viral yield in vaccines and viral medicines; chemical and biochemical products for scientific use and for research, namely, chemical preparations for scientific purposes, laboratory and research use; chemical and biochemical products for scientific use and for research, namely, chemical preparations for scientific purposes, reagents for scientific and research use, in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses, and pseudo-viral particles; chemical or biochemical transfection test kits for virus manufacturing for scientific use and for research containing preparations, agents and reagents
Goods and ServicesBiological production in the field of gene therapy and cell therapies; scientific research and analysis in the field of gene and cell therapies; biological production in the field of vaccines; scientific research and analysis in the field of vaccines, process development and evaluation; research and development in the field of vaccines; testing services in the field of vaccines; laboratory research in the field of gene expression; research in the field of gene therapy; research and development in the medical biotechnology field; development of biotechnology; research and development in the pharmaceutical and biotechnology fields

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, March 1, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 1, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVirica Biotech Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOttawa, Ontario K1Y2C5
CA

Trademark Events

Event DateEvent Description
Friday, March 1, 2024NEW APPLICATION ENTERED
Sunday, July 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 17, 2024ASSIGNED TO EXAMINER
Wednesday, September 18, 2024NON-FINAL ACTION WRITTEN
Wednesday, September 18, 2024NON-FINAL ACTION E-MAILED
Wednesday, September 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

virica research scientific field chemical preparations purposes reagents development vaccines cell